Skip to Main Content

Tezepelumab COPD Exacerbation Study (COURSE)

Conditions

Asthma | Diseases of the Lung

Phase IIA

What is the purpose of this trial?

To evaluate the effect of tezepelumab as compared with placebo on COPD exacerbations in subjects with moderate to very severe COPD

  • Trial with
    Astra Zeneca
  • Start Date
    01/07/2020
  • End Date
    02/13/2022
Trial Image

For more information about this study, contact:

Terri-Dawn Levesh

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/24/2020
  • Study HIC
    #2000026323